Xu, H. C.;# Wang, M. S.;# Wu, X. F.;# Zhuo, L. S.*; Huang, W.*; She, N. F.* Discovery of N-substituted-3-phenyl-1,6-naphthyridinone Derivatives Bearing Quinoline Moiety as VEGFR-2 Selective Type II c-Met Kinase Inhibitors against VEGFR-2. Bioorg. Med. Chem. 2020, 28, 115555. (IF2020 = 3.641，二区)
发布时间：2026-06-15
点击次数：
- 发布时间：
- 2026-06-15
- 论文名称：
- Xu, H. C.;# Wang, M. S.;# Wu, X. F.;# Zhuo, L. S.*; Huang, W.*; She, N. F.* Discovery of N-substituted-3-phenyl-1,6-naphthyridinone Derivatives Bearing Quinoline Moiety as VEGFR-2 Selective Type II c-Met Kinase Inhibitors against VEGFR-2. Bioorg. Med. Chem. 2020, 28, 115555. (IF2020 = 3.641，二区)
- 是否译文：
- 否
- 上一条：Wang, M. S.;# Xu, H. C.;# Gong, Y.;# Qu, R. Y.; Zhuo, L. S.;* Huang, W.* Efficient Arylation of 2,7-Naphthyridin-1(2H)‑one with Diaryliodonium Salts and Discovery of a New Selective MET/AXL Kinase Inhibitor. ACS. Comb. Sci. 2020, 22, 457-467. (IF2020 = 3.784，二区)
- 下一条：Wu, X. F.;# Zhuo, L. S.;# Wang, F.; Huang, W.;* Hao, G. F.;* Yang, G. F.* Auto in silico ligand directing evolutionto facilitate the rapid and efficient discovery of drug lead. iScience 2020, 23, 101179. (IF2020 = 5.458，二区)